ONVO Organovo Holdings Inc Return on Sales by Gross Profit

ONVO (Organovo Holdings) - company brandmark

Organovo Holdings, Inc. (ONVO) develops 3D bioprinting of tissues by uniting leading biologists and engineers within a futuristic environment. The gross margin share of revenue confirms production efficiency, where the current metric stands at -130.30. The recruitment of top specialists is bolstered by a mission to transform medicine. Meanwhile, long-term drivers for the validation of platforms for metabolic drug testing are already priced in by the market.

Organovo Holdings Inc (ONVO): Gross Profitability from 07/04/2022 to 04/24/2025

Financial and market metric breakdowns for Organovo Corp (ONVO)

- current quotes and average value forecast:
Fundamental valuation:Organovo Holdings, Inc.
Manufactured products of Organovo Holdings Inc

Gross margin measures production efficiency by determining the profit share remaining after deducting all direct costs of product creation. The dynamics of this ratio allow an investor to assess a business's ability to control cost of goods sold and withstand inflationary shocks. By analyzing the monthly gross margin, one can track how the robotization of 3D bioprinting at Organovo Holdings, Inc. (ONVO) reduces reliance on expensive manual labor, thereby optimizing operating profitability.